X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective

X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective

X-linked lymphoproliferative disease (XLP) was first described in the 1970s as a fatal lymphoproliferative syndrome associated with infection with Epstein–Barr virus (EBV). Features include hemophagocytic lymphohistiocytosis (HLH), lymphomas, and dysgammaglobulinemias. Molecular cloning of the causa...

Full description

Bibliographic Details
Main Authors: Neelam Panchal, Claire Booth, Jennifer L. Cannons, Pamela L. Schwartzberg
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-04-01
Series:Frontiers in Immunology
Subjects:
X-linked lymphoproliferative disease 1
Epstein–Barr virus
SAP (signaling lymphocyte activation molecule-associated protein)
signaling lymphocytic activation molecule
primary immunodeficiency disease
hemophagocytic lymphohistiocytosis
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2018.00666/full

Internet

http://journal.frontiersin.org/article/10.3389/fimmu.2018.00666/full

Similar Items